EN DE
Watch Daishin Balance No.8 Special Purpose Acquisition Co. Ltd for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570) fair value: what the stock is really worth

As of Nov 9, 2026: fair value (intrinsic value) of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd stock KRW 10,380, price KRW 3,460, upside +200.0%, quality 76 out of 100. Rating: strongly undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare KR

DB Daishin Balance No.8 Special Purpose Acquisition Co. Ltd logo Thin data Nov 6, 2026

Daishin Balance No.8 Special Purpose Acquisition Co. Ltd

336570 · KQ
Undervalued, but in a downtrend

The stock costs 67% less than our calculation considers fair.

Fair value 10,380 KRW · Strongly undervalued
Quality 76/100
Highly profitable · 23.9% net margin (TTM)
Low debt
Generates free cash flow
1.4% dividend yield · Well covered
Ranks above peers (12/14)
Last quarter vs. a year ago: revenue +19%, profit +66%.
Mixed Growth (revenue 3y +24.4 %/yr in KRW)
Wide moat 84/100 · thin data
Thin data
Watch Daishin Balance No.8 Special Purpose Acquisition Co. Ltd for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

14,586 KRW 2,018 KRW Fair Value 10,380 KRW Dec 2020 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.

How to read this chart

60‑month range 2,018 KRW – 14,586 KRW · fair‑value band 6,655 KRW – 16,199 KRW · the 3,460 KRW price screens below the 10,380 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.

Follow Daishin Balance No.8 Special Purpose Acquisition Co. in your weekly email

Every Wednesday you see whether Daishin Balance No.8 Special Purpose Acquisition Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

WON TECH Co.,Ltd. engages in the production and sale of laser and energy-based equipment in South Korea and internationally. The company offers aesthetics, skincare, homecare, and surgical usage equipment.

Show moreShow less

It also provides products for the treatments, including face lifting and tightening, body contouring, skin rejuvenation, tattoo removal, scars and striae, vascular lesions, hair removal, and surgical. The company was formerly known as WONTECHnology and changed its name to WON TECH Co.,Ltd. in 2013.

WON TECH Co.,Ltd. was founded in 1999 and is headquartered in Daejeon, South Korea.

Stock analysis

Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570) currently trades at 3,460 KRW, while our model-based Fair Value estimate is 10,380 KRW, implying the stock looks roughly 67% undervalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 16,648 KRW per share, and 22 of the 26 models we run sit above the 3,460 KRW price.

Bear case: the Asset-Based group reads lowest at 1,402 KRW, and 4 of the 26 models stay below the price. Data coverage for this calculation is low.

Scenario range: 6,655 KRW (bear) to 16,199 KRW (bull), the price of 3,460 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 76/100 (high quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Daishin Balance No.8 Special Purpose Acquisition Co. Ltd reported revenue of 157B KRW in FY2025 versus 51.1B KRW in FY2021, a compound +32.4%/yr. Reported net income was 35.2B KRW in FY2025.

Key figures

Market cap 304B KRW (≈ $225M) Micro · P/E ratio 8.2 · P/S ratio 1.82 · EPS (TTM) 453.19 KRW · Dividend yield 1.4% · Net margin 23.9% · Return on equity 24.9% · Return on assets (EBIT) 21.7% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 84 out of 100 (low confidence).

What moves the price

The share trades about 66% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −15% fair-value upside, at 200%, 336570 screens cheaper than that median.

Fair Value models

Bear 6,655 KRW Fair Value 10,380 KRW Bull 16,199 KRW
Price 3,460 KRW · Upside +200.0%
Capped: our models arrive at a very high value here. We deliberately show a more cautious Fair Value.
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (345.75 KRW per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF 7,125 KRW 9,758 KRW 17,409 KRW 78
Growth DCF 6,698 KRW 10,446 KRW 16,302 KRW 77
EPV 4,033 KRW 4,460 KRW 4,805 KRW 74
All 26 models by family
DCF Models
FCF DCF 7,125 KRW 9,758 KRW 17,409 KRW 78
Owner Earnings 5,672 KRW 10,666 KRW 19,269 KRW 73
5Y Revenue Exit 5,363 KRW 8,372 KRW 14,618 KRW 70
5Y EBITDA Exit 6,951 KRW 11,575 KRW 20,622 KRW 72
5Y P/E Exit 7,008 KRW 14,428 KRW 24,404 KRW 68
10Y Revenue Exit 5,890 KRW 10,867 KRW 13,589 KRW 67
10Y EBITDA Exit 6,985 KRW 13,731 KRW 25,104 KRW 65
10Y P/E Exit 7,020 KRW 13,834 KRW 24,710 KRW 61
Earnings-Based
Graham-Dodd 2,714 KRW 18,930 KRW 26,566 KRW 63
Lynch FV 8,545 KRW 12,207 KRW 15,869 KRW 61
PEG = 1.0 8,545 KRW 12,207 KRW 15,869 KRW 57
EPV 4,033 KRW 4,460 KRW 4,805 KRW 74
Dividend Discount
Gordon GGM 342.34 KRW 564.65 KRW 724.56 KRW 68
DDM Multi-Stage 342.34 KRW 539.63 KRW 608.25 KRW 67
Multiples
P/E Multiple 6,587 KRW 8,782 KRW 10,978 KRW 63
P/S Multiple 4,666 KRW 6,222 KRW 7,777 KRW 58
P/B Multiple 5,926 KRW 7,902 KRW 9,877 KRW 55
EV/EBIT 7,417 KRW 9,907 KRW 12,397 KRW 66
EV/EBITDA 6,446 KRW 8,612 KRW 10,777 KRW 67
EV/Revenue 3,681 KRW 5,281 KRW 6,881 KRW 53
Asset-Based
NCAV (Graham) 925.33 KRW 1,402 KRW 1,753 KRW 54
Growth DCF
Growth DCF 6,698 KRW 10,446 KRW 16,302 KRW 77
Rev-Margin DCF 5,680 KRW 9,525 KRW 17,266 KRW 70
Economic Profit
Residual Income 1,994 KRW 2,837 KRW 5,051 KRW 72
ROIC Compounder 4,871 KRW 6,535 KRW 8,480 KRW 72
Growth Earnings
Growth-Adj P/E 11,653 KRW 16,648 KRW 21,642 KRW 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 76/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 80
How much profit the company makes from its sales and capital
Quality Growth 64
Are margins and returns getting better?
Cashflow 91
Do the profits arrive as real cash?
Financial strength 89
Debt, balance sheet and risk of trouble
Investment 33
Does it invest with discipline instead of growing at any price?
Low Volatility 34
How calm the share price moves, does not count
Price momentum 3
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 74
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 90/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+36.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+24.4%
What shareholders gained per year (last 3 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+11.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year+9.7%
Dividend (yield on the price)1.4%
Profit margin 2021 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.0% → 33%

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−11.0%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+17.0%
Yearly sales growth analysts expect, extended to five years.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about −12.8% a year for the price and +14.7% for the forecasts.
Forecast 2026 (sales)+19.7%
Forecast 2027 (sales)+19.7%
Projected 2028 (sales)+17.5%
Projected 2029 (sales)+15.3%
Projected 2030 (sales)+13.1%

Watch 336570, get fair value alerts →

Compare Daishin Balance No.8 Special Purpose Acquisition Co. Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 319 stocks

Beats the industry median on 12/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 76 · Top 25%
Fair Value upside +200.0% · Top 25%
Profitability
Return on equity (12 months) 24.9% · Top 25%
Return on assets 16.2% · Top 25%
Net margin (12 months) 23.9% · Top 25%
Operating margin (12 months) 23.4% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) 19.3% · Top 25%
Dividend yield (12 months) 1.4% · Below median
Balance sheet
Debt / equity 0.00× · Lowest 25%

Valuation Multiplesvs Medical Devices median · lower = cheaper

P/E (12 months) 8.2× · Cheapest 25%
P/B 1.93× · Pricier than median
P/S (12 months) 1.82× · Cheaper than median
Price / free cash flow (fiscal year) 6.1× · Cheapest 25%
EV/EBITDA 6.0× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 6
FUTURE (revenue growth)97 · sector 36
PAST (return on equity)99 · sector 17
HEALTH (low debt)100 · sector 98
DIVIDEND (yield)29 · sector 34

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate.

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Daishin Balance No.8 Special Purpose Acquisition Co. Ltd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Daishin Balance No.8 Special Purpose Acquisition Co. Ltd Fair Value". https://www.fairvalue-calculator.com/stock/336570

Frequently asked questions

Is Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of 10,380 KRW versus a price of 3,460 KRW, about +200% upside (undervalued).
What is the fair value of 336570?
Our model-based fair value for Daishin Balance No.8 Special Purpose Acquisition Co. Ltd is 10,380 KRW (as of Nov 6, 2026), built from audited fundamentals. The current price: 3,460 KRW.
What is the quality score of 336570?
Daishin Balance No.8 Special Purpose Acquisition Co. Ltd has a Quality Score of 76/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570)?
Our model-based price target is the fair value of 10,380 KRW (as of Nov 6, 2026) from 26 valuation models. Cautious scenario 6,655 KRW, optimistic scenario 16,199 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Daishin Balance No.8 Special Purpose Acquisition Co. Ltd stock forecast for 2026?
Our models put fair value at 10,380 KRW, about +200% upside versus a price of 3,460 KRW (undervalued). Cautious scenario 6,655 KRW, optimistic scenario 16,199 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570)?
Daishin Balance No.8 Special Purpose Acquisition Co. Ltd reported trailing-twelve-month revenue of about 167B KRW (latest available figure, as of Nov 6, 2026).
Does Daishin Balance No.8 Special Purpose Acquisition Co. Ltd pay a dividend?
Daishin Balance No.8 Special Purpose Acquisition Co. Ltd currently shows a dividend yield of 1.45% relative to its recent price (as of Nov 6, 2026).
How much is the dividend of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570) and when is the ex-dividend date?
Daishin Balance No.8 Special Purpose Acquisition Co. Ltd pays a dividend of 50.00 KRW per share a year, a dividend yield of 1.4%. The last ex-dividend date was Dec 29, 2025. The payout ratio is 11.0% of earnings. Free cash flow covers the dividend 11.29 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570)?
For today's price to be fair in a discounted-cash-flow model, Daishin Balance No.8 Special Purpose Acquisition Co. Ltd would have to grow free cash flow by -11.0 % per year for five years (discount rate 12.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 4 years revenue grew +32.4 % per year. As of Nov 6, 2026.
What discount rate (WACC) does the fair value of 336570 use?
Our models discount Daishin Balance No.8 Special Purpose Acquisition Co. Ltd at 12.9 %: a base by market capitalisation (micro), damped by beta 0.92, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Daishin Balance No.8 Special Purpose Acquisition Co. Ltd that is -11.0 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (12.9 %) and the same formula as our fair value.
How much growth has Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570) delivered so far?
Over the past 4 years revenue at Daishin Balance No.8 Special Purpose Acquisition Co. Ltd grew +32.4 % a year. The price currently implies free-cash-flow growth of -11.0 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570) growing?
The median revenue growth in the sector is +14.2 % a year. That is the yardstick for the growth priced into Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (-11.0 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570)?
The free-cash-flow yield on the price is 16.00 %: that much free cash flow Daishin Balance No.8 Special Purpose Acquisition Co. Ltd produces per unit of market value. When it exceeds the discount rate of our models (12.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Daishin Balance No.8 Special Purpose Acquisition Co. Ltd it is 10,380 KRW per share (as of Nov 6, 2026), against a price of 3,460 KRW. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Daishin Balance No.8 Special Purpose Acquisition Co. Ltd stock overvalued or undervalued in 2026?
As of Nov 6, 2026, 336570 trades below its calculated fair value: price 3,460 KRW, fair value 10,380 KRW, a gap of about +200% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 336570?
No. The price is what the market pays today (3,460 KRW); the fair value is what the company's own numbers justify (10,380 KRW). For Daishin Balance No.8 Special Purpose Acquisition Co. Ltd the two are 6,920 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Daishin Balance No.8 Special Purpose Acquisition Co. Ltd worth?
The market values Daishin Balance No.8 Special Purpose Acquisition Co. Ltd at about 304B KRW (market capitalisation, as of Nov 6, 2026). Per share that is 3,460 KRW; our models calculate a fair value of 10,380 KRW per share.
What do the bullish and bearish scenarios say about 336570?
Our models span a range for Daishin Balance No.8 Special Purpose Acquisition Co. Ltd: cautious scenario 6,655 KRW, base 10,380 KRW, optimistic 16,199 KRW per share (as of Nov 6, 2026, price 3,460 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 336570?
Daishin Balance No.8 Special Purpose Acquisition Co. Ltd trades at a price-to-earnings ratio of 8.2 (as of Nov 6, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 10,380 KRW is built from several models across several years. Median P/E at fiscal year-end, 5 fiscal years (2020 to 2025), reported earnings, FY2025 ex one-offs: 21.2. Other multiples: P/B 1.9, P/S 1.8, EV/EBITDA 6.0.
How solid is the balance sheet of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570)?
Balance-sheet figures for Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (as of Nov 6, 2026): return on equity 24.9%, debt of 0.00 per unit of equity. They feed the Quality Score of 76/100, which measures business quality independently of the share price.
How far is 336570 from its 52-week high?
Daishin Balance No.8 Special Purpose Acquisition Co. Ltd trades at 3,460 KRW, about 66% below its 52-week high of 10,220 KRW and at the low of 3,460 KRW (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of 10,380 KRW is for.
Which stocks are comparable to Daishin Balance No.8 Special Purpose Acquisition Co. Ltd?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Daishin Balance No.8 Special Purpose Acquisition Co. Ltd stock attractive at the current price?
The data as of Nov 6, 2026: price 3,460 KRW, calculated fair value 10,380 KRW (+200%), Quality Score 76/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 336570 calculated?
We run Daishin Balance No.8 Special Purpose Acquisition Co. Ltd through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 10,380 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Daishin Balance No.8 Special Purpose Acquisition Co. Ltd currently trades 67% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570)?
The closing price on Nov 9, 2026 was 3,460 KRW. Our model-based fair value is 10,380 KRW, about +200% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Daishin Balance No.8 Special Purpose Acquisition Co. Ltd right now?
The rarer combination: high quality (76/100) AND below fair value. That earns a closer look rather than a quick verdict. The price is below even our cautious bear case (6,655 KRW). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (6,655 KRW to 16,199 KRW) leaves room in how you read the outcome.

Key figures of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd

How large is the market capitalisation of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570)?
The market capitalisation of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd is 304B KRW (≈ $225M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570)?
The price-to-sales ratio of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd is 1.82 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570)?
Earnings per share at Daishin Balance No.8 Special Purpose Acquisition Co. Ltd are 453.19 KRW (price ÷ EPS = P/E 8.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570)?
The dividend yield of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd is 1.4% (payout 11.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570)?
The net margin of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd is 23.9% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570)?
The return on equity (ROE) of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd is 24.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570)?
On an EBIT basis the return on assets of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd is 21.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570)?
The operating margin of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd is 23.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570)?
Revenue at Daishin Balance No.8 Special Purpose Acquisition Co. Ltd is growing +19.3% versus a year earlier (3y avg +24.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570)?
Earnings per share at Daishin Balance No.8 Special Purpose Acquisition Co. Ltd are growing +66.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570) carry?
The net debt of Daishin Balance No.8 Special Purpose Acquisition Co. Ltd is 4.5B KRW (fiscal year 2023, ≈ 0.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Daishin Balance No.8 Special Purpose Acquisition Co. Ltd in the live analysis

One click puts Daishin Balance No.8 Special Purpose Acquisition Co. Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.